Cargando…
Efficacy and Safety of Novel Oral Anticoagulants for Atrial Fibrillation Ablation: An Updated Meta-Analysis
INTRODUCTION: Novel oral anticoagulants (NOACs) have been approved for prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation (NVAF). A large number of patients are on NOACs when they present for AF ablation. We intended to evaluate the safety and efficacy of NO...
Autores principales: | Vallakati, Ajay, Sharma, Abhishek, Madmani, Mohammed, Reddy, Madhu, Kanmanthareddy, Arun, Gunda, Sampath, Lakkireddy, Dhanunjaya, Lewis, William R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4906088/ https://www.ncbi.nlm.nih.gov/pubmed/27105998 http://dx.doi.org/10.1007/s40119-016-0061-7 |
Ejemplares similares
-
Comparison of peri-procedural anticoagulation with rivaroxaban and apixaban during radiofrequency ablation of atrial fibrillation
por: Pillarisetti, Jayasree, et al.
Publicado: (2020) -
Simultaneous appendage ligation and atrial ablation – is it worth the risk?
por: Garg, Jalaj, et al.
Publicado: (2021) -
Incidence, predictors and outcomes of hematoma after ICD implantation: An analysis of a nationwide database of 85,276 patients
por: Sridhar, Arun Raghav Mahankali, et al.
Publicado: (2016) -
Periprocedural anticoagulation in atrial fibrillation: Update on electrical cardioversion and ablation
por: van Vugt, S. P. G., et al.
Publicado: (2018) -
Novel Oral Anticoagulants in Atrial Fibrillation: Update on Apixaban
por: Mezue, Kenechukwu, et al.
Publicado: (2017)